These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35525134)

  • 1. Re-analysis of the Hungarian amyotrophic lateral sclerosis population and evaluation of novel ALS genetic risk variants.
    Nagy ZF; Pál M; Salamon A; Kafui Esi Zodanu G; Füstös D; Klivényi P; Széll M
    Neurobiol Aging; 2022 Aug; 116():1-11. PubMed ID: 35525134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variability in sporadic amyotrophic lateral sclerosis.
    Van Daele SH; Moisse M; van Vugt JJFA; Zwamborn RAJ; van der Spek R; van Rheenen W; Van Eijk K; Kenna K; Corcia P; Vourc'h P; Couratier P; Hardiman O; McLaughin R; Gotkine M; Drory V; Ticozzi N; Silani V; Ratti A; de Carvalho M; Mora Pardina JS; Povedano M; Andersen PM; Weber M; Başak NA; Shaw C; Shaw PJ; Morrison KE; Landers JE; Glass JD; van Es MA; van den Berg LH; Al-Chalabi A; Veldink J; Van Damme P
    Brain; 2023 Sep; 146(9):3760-3769. PubMed ID: 37043475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond C9orf72: repeat expansions and copy number variations as risk factors of amyotrophic lateral sclerosis across various populations.
    Nagy ZF; Pál M; Engelhardt JI; Molnár MJ; Klivényi P; Széll M
    BMC Med Genomics; 2024 Jan; 17(1):30. PubMed ID: 38254109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OPTN p.Met468Arg and ATXN2 intermediate length polyQ extension in families with C9orf72 mediated amyotrophic lateral sclerosis and frontotemporal dementia.
    Farhan SMK; Gendron TF; Petrucelli L; Hegele RA; Strong MJ
    Am J Med Genet B Neuropsychiatr Genet; 2018 Jan; 177(1):75-85. PubMed ID: 29080331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic analysis of the SOD1 and C9ORF72 genes in Hungarian patients with amyotrophic lateral sclerosis.
    Tripolszki K; Csányi B; Nagy D; Ratti A; Tiloca C; Silani V; Kereszty É; Török N; Vécsei L; Engelhardt JI; Klivényi P; Nagy N; Széll M
    Neurobiol Aging; 2017 May; 53():195.e1-195.e5. PubMed ID: 28222900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATXN1 intermediate-length polyglutamine expansions are associated with amyotrophic lateral sclerosis.
    Lattante S; Pomponi MG; Conte A; Marangi G; Bisogni G; Patanella AK; Meleo E; Lunetta C; Riva N; Mosca L; Carrera P; Bee M; Zollino M; Sabatelli M
    Neurobiol Aging; 2018 Apr; 64():157.e1-157.e5. PubMed ID: 29274668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple variants in families with amyotrophic lateral sclerosis and frontotemporal dementia related to C9orf72 repeat expansion: further observations on their oligogenic nature.
    Giannoccaro MP; Bartoletti-Stella A; Piras S; Pession A; De Massis P; Oppi F; Stanzani-Maserati M; Pasini E; Baiardi S; Avoni P; Parchi P; Liguori R; Capellari S
    J Neurol; 2017 Jul; 264(7):1426-1433. PubMed ID: 28620717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive Genetic Analysis of a Hungarian Amyotrophic Lateral Sclerosis Cohort.
    Tripolszki K; Gampawar P; Schmidt H; Nagy ZF; Nagy D; Klivényi P; Engelhardt JI; Széll M
    Front Genet; 2019; 10():732. PubMed ID: 31475037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyotrophic lateral sclerosis and cerebellum.
    Kabiljo R; Iacoangeli A; Al-Chalabi A; Rosenzweig I
    Sci Rep; 2022 Jul; 12(1):12586. PubMed ID: 35869263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C9orf72 hexanucleotide repeat expansions and Ataxin 2 intermediate length repeat expansions in Indian patients with amyotrophic lateral sclerosis.
    Narain P; Gomes J; Bhatia R; Singh I; Vivekanandan P
    Neurobiol Aging; 2017 Aug; 56():211.e9-211.e14. PubMed ID: 28527524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyotrophic lateral sclerosis onset is influenced by the burden of rare variants in known amyotrophic lateral sclerosis genes.
    Cady J; Allred P; Bali T; Pestronk A; Goate A; Miller TM; Mitra RD; Ravits J; Harms MB; Baloh RH
    Ann Neurol; 2015 Jan; 77(1):100-13. PubMed ID: 25382069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted next-generation sequencing study in familial ALS-FTD Portuguese patients negative for C9orf72 HRE.
    Gromicho M; Coutinho AM; Pronto-Laborinho AC; Raposeiro R; Tavares J; Antunes D; de Carvalho M
    J Neurol; 2020 Dec; 267(12):3578-3592. PubMed ID: 32638105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The most prevalent genetic cause of ALS-FTD, C9orf72 synergizes the toxicity of ATXN2 intermediate polyglutamine repeats through the autophagy pathway.
    Ciura S; Sellier C; Campanari ML; Charlet-Berguerand N; Kabashi E
    Autophagy; 2016 Aug; 12(8):1406-8. PubMed ID: 27245636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Epidemiology of Amyotrophic Lateral Sclerosis in Norway: A 2-Year Population-Based Study.
    Olsen CG; Busk ØL; Aanjesen TN; Alstadhaug KB; Bjørnå IK; Braathen GJ; Breivik KL; Demic N; Flemmen HØ; Hallerstig E; HogenEsch I; Holla ØL; Jøntvedt AB; Kampman MT; Kleveland G; Kvernmo HB; Ljøstad U; Maniaol A; Morsund ÅH; Nakken O; Novy C; Rekand T; Schlüter K; Schüler S; Tveten K; Tysnes OB; Holmøy T; Høyer H
    Neuroepidemiology; 2022; 56(4):271-282. PubMed ID: 35576897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of ATXN2 intermediary polyQ expansions in a spectrum of neurodegenerative disorders.
    Lattante S; Millecamps S; Stevanin G; Rivaud-Péchoux S; Moigneu C; Camuzat A; Da Barroca S; Mundwiller E; Couarch P; Salachas F; Hannequin D; Meininger V; Pasquier F; Seilhean D; Couratier P; Danel-Brunaud V; Bonnet AM; Tranchant C; LeGuern E; Brice A; Le Ber I; Kabashi E;
    Neurology; 2014 Sep; 83(11):990-5. PubMed ID: 25098532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The First Historically Reported Italian Family with FTD/ALS Teaches a Lesson on C9orf72 RE: Clinical Heterogeneity and Oligogenic Inheritance.
    Giannoccaro MP; Bartoletti-Stella A; Piras S; Casalena A; Oppi F; Ambrosetto G; Montagna P; Liguori R; Parchi P; Capellari S
    J Alzheimers Dis; 2018; 62(2):687-697. PubMed ID: 29480190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation analysis of SOD1, C9orf72, TARDBP and FUS genes in ethnically-diverse Malaysian patients with amyotrophic lateral sclerosis (ALS).
    Edgar S; Ellis M; Abdul-Aziz NA; Goh KJ; Shahrizaila N; Kennerson ML; Ahmad-Annuar A
    Neurobiol Aging; 2021 Dec; 108():200-206. PubMed ID: 34404558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion.
    Chiò A; Mora G; Sabatelli M; Caponnetto C; Lunetta C; Traynor BJ; Johnson JO; Nalls MA; Calvo A; Moglia C; Borghero G; Trojsi F; La Bella V; Volanti P; Simone I; Salvi F; Logullo FO; Riva N; Carrera P; Giannini F; Mandrioli J; Tanel R; Capasso M; Tremolizzo L; Battistini S; Murru MR; Origone P; Zollino M; Penco S; ; ; Mazzini L; D'Alfonso S; Restagno G; Brunetti M; Barberis M; Conforti FL
    Neurobiol Aging; 2016 Mar; 39():218.e5-8. PubMed ID: 26733254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive analysis of the mutation spectrum in 301 German ALS families.
    Müller K; Brenner D; Weydt P; Meyer T; Grehl T; Petri S; Grosskreutz J; Schuster J; Volk AE; Borck G; Kubisch C; Klopstock T; Zeller D; Jablonka S; Sendtner M; Klebe S; Knehr A; Günther K; Weis J; Claeys KG; Schrank B; Sperfeld AD; Hübers A; Otto M; Dorst J; Meitinger T; Strom TM; Andersen PM; Ludolph AC; Weishaupt JH;
    J Neurol Neurosurg Psychiatry; 2018 Aug; 89(8):817-827. PubMed ID: 29650794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TDP-43 levels in the brain tissue of ALS cases with and without
    Yang Y; Halliday GM; Kiernan MC; Tan RH
    Neurology; 2019 Nov; 93(19):e1748-e1755. PubMed ID: 31619481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.